Estrella Immunopharma Inc. share price logo

Estrella Immunopharma Inc. Share Price

NASDAQ: ESLA

Small Cap

$1.78

-0.02

(-1.11%)

Live

as on

Estrella Immunopharma Inc. Stock Performance

as on April 24, 2026 at 1:00 am IST

  • Day's Low

    Day's High

    $1.77
    $1.82
    downward going graph

    0.56%

    Downside

    2.25%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.78
    $3.15
    downward going graph

    56.18%

    Downside

    76.97%

    Upside

    downward going graph

Estrella Immunopharma Inc. share price movements today

Previous Close
$1.80
Open
$1.77
Volume
5.5K
Day's Low - High
$1.77 - $1.82
52 Week Low - High
$0.78 - $3.15

Estrella Immunopharma Inc. Historical Returns

1 Month Return
+ 76.47 %
3 Month Return
+ 78.22 %
1 Year Return
+ 76.49 %
3 Year Return
0 %
5 Year Return
0 %

Estrella Immunopharma Inc. Stock Fundamentals & Key Indicators

Check Estrella Immunopharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$77.2M

EPS (TTM)

-0.39

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-268.50%

Estrella Immunopharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Estrella Immunopharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$77.2MNANA0.00%
BUY$41.2B127.17%131.818.45%
BUY$111.1B100.86%28.532.94%
NA$34.7BNA126.485.37%
BUY$79.0B52.79%18.0231.41%

Stock Returns calculator for Estrella Immunopharma Inc. Stock including INR - Dollar returns

The Estrella Immunopharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Estrella Immunopharma Inc. investment value today

Current value as on today

₹1,92,754

Returns

₹92,754

(+92.75%)

Returns from Estrella Immunopharma Inc. Stock

₹74,510 (+74.51%)

Dollar Impact

₹18,244 (+18.24%)

Estrella Immunopharma Inc. Stock’s Investor Sentiment and Interest

Search interest for Estrella Immunopharma Inc. Stock has increased by 278% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:278% versus previous 30 day period

Estrella Immunopharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
Operating Income
-1
-1
0
-3
-3
-2
-5
-4
0
EBITDA
-1
0
0
-3
-3
-2
-5
-4
0
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
-1
0
-3
-3
-2
-5
-4
0
Income Tax Expense
0
0
0
0
0
0
0
-
0
Net Income
-1
-1
0
-3
-3
-2
-5
-4
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Estrella Immunopharma Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
Operating Income
0
-
-1
-
-1
-
-7
-13
EBITDA
0
-
-1
-
0
-
-
-13
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
0
-
-1
-
0
-
-7
-13
Income Tax Expense
0
-
0
-
0
-
-
0
Net Income
0
0
-1
-1
0
0
-7
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Estrella Immunopharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
0
-3
-3
-1
-2
-5
-4
0
Operating Cash Flow
-11
-4
0
-2
0
0
0
0
0
Investing Cash Flow
5
-
-
-
-
-
-
-
-
Financing Cash Flow
-6
0
0
0
0
0
1
1
0
Change in Cash
-13
-4
0
-2
0
0
0
0
0

Estrella Immunopharma Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
0
-7
-8
-13
Operating Cash Flow
-1
-1
-16
-7
-1
Investing Cash Flow
-45
36
-
4
-
Financing Cash Flow
5
-35
12
0
2
Change in Cash
4
0
1
-8
0

Insights on Estrella Immunopharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ESLA stock has moved up by 76.5%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ESLA has outperformed top 5 stocks with highest market-cap in its industry

About Estrella Immunopharma Inc.

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase I/II clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It offers ARTEMIS, a cell receptor platform to develop and commercialize T-cell therapies targeting CD19 and CD22 for the treatment of hematologic malignancies. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California. Estrella Immunopharma, Inc. is a subsidiary of Eureka Therapeutics, Inc.
OrganisationEstrella Immunopharma Inc.
Headquarters5858 Horton Street, EmeryVille, CA, United States, 94608
IndustryBiotechnology
CEODr. Cheng Liu Ph.D.
E-voting on sharesClick here to vote

Key Management of Estrella Immunopharma Inc.

Name

Title

Dr. Cheng Liu Ph.D.

CEO, President & Director

Mr. Jiandong Xu

Chief Financial Officer

FAQs

What is Estrella Immunopharma Inc. share price today?

Estrella Immunopharma Inc. share price today is $1.78 as on . Estrella Immunopharma Inc. share today touched a day high of $1.82 and a low of $1.77.

What is the 52 week high and 52 week low for Estrella Immunopharma Inc. share?

Estrella Immunopharma Inc. share touched a 52 week high of $3.15 on and a 52 week low of $0.78 on . Estrella Immunopharma Inc. stock price today i.e. is trending at $1.78,which is 43.49% down from its 52 week high and 128.21% up from its 52 week low.

What is Estrella Immunopharma Inc.'s market capitalisation today?

Estrella Immunopharma Inc. market capitalisation is $0.00T as on .

How to invest in Estrella Immunopharma Inc. Stock (ESLA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Estrella Immunopharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Estrella Immunopharma Inc. Shares that will get you 0.8427 shares as per Estrella Immunopharma Inc. share price of $1.78 per share as on April 23, 2026 at 7:30 pm IST.

What is the minimum amount required to buy Estrella Immunopharma Inc. Stock (ESLA) from India?

Indian investors can start investing in Estrella Immunopharma Inc. (ESLA) shares with as little as ₹94.085 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.85 in Estrella Immunopharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Estrella Immunopharma Inc. share’s latest price of $1.78 as on April 23, 2026 at 7:30 pm IST, you will get 5.6180 shares of Estrella Immunopharma Inc.. Learn more about fractional shares .